Core Scientific, Inc. (CORZ)
NASDAQ: CORZ · Real-Time Price · USD
16.47
+0.87 (5.58%)
At close: Nov 19, 2024, 4:00 PM
16.60
+0.13 (0.79%)
After-hours: Nov 19, 2024, 7:56 PM EST
Core Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 116.67 | 112.07 | 242.52 | 327.56 | 54.19 | 53.88 |
| Other Revenue | 441.01 | 390.33 | 397.8 | 216.93 | 6.13 | 5.65 |
| Revenue | 557.68 | 502.4 | 640.31 | 544.48 | 60.32 | 59.52 |
| Revenue Growth (YoY) | 15.77% | -21.54% | 17.60% | 802.66% | 1.34% | - |
| Cost of Revenue | 394.14 | 378.94 | 631.91 | 305.62 | 50.93 | 49 |
| Gross Profit | 163.54 | 123.46 | 8.4 | 238.86 | 9.39 | 10.53 |
| Selling, General & Admin | 117.89 | 100.93 | 223.71 | 64.55 | 16.33 | 16.61 |
| Research & Development | 8.69 | 7.18 | 26.96 | 7.67 | 5.27 | 5.48 |
| Other Operating Expenses | 3.01 | 0.51 | 187.02 | 32.39 | -0.07 | -0.81 |
| Operating Expenses | 129.6 | 108.62 | 437.69 | 104.61 | 21.53 | 21.28 |
| Operating Income | 33.94 | 14.84 | -429.29 | 134.25 | -12.14 | -10.76 |
| Interest Expense | -119.86 | -86.24 | -96.83 | -44.35 | -4.44 | -0.24 |
| Currency Exchange Gain (Loss) | -1.96 | -1.96 | -28.03 | -0.12 | -0 | - |
| Other Non Operating Income (Expenses) | -1,150 | -1.39 | 42.2 | -0 | -0.11 | - |
| EBT Excluding Unusual Items | -1,238 | -74.75 | -511.94 | 89.77 | -16.69 | -10.99 |
| Merger & Restructuring Charges | - | - | -6.8 | - | - | - |
| Impairment of Goodwill | - | - | -1,055 | - | - | - |
| Asset Writedown | - | - | -590.74 | - | - | -0.93 |
| Legal Settlements | - | - | - | -2.64 | 5.81 | - |
| Other Unusual Items | -2.97 | -171.06 | 0.77 | -24.06 | -1.33 | - |
| Pretax Income | -1,244 | -245.8 | -2,163 | 63.08 | -12.21 | -11.92 |
| Income Tax Expense | 0.82 | 0.68 | -17.09 | 15.76 | - | - |
| Net Income | -1,245 | -246.49 | -2,146 | 47.31 | -12.21 | -11.92 |
| Preferred Dividends & Other Adjustments | -111.83 | - | - | - | 10.48 | - |
| Net Income to Common | -1,133 | -246.49 | -2,146 | 47.31 | -22.68 | -11.92 |
| Shares Outstanding (Basic) | 286 | 380 | 341 | 207 | 158 | 99 |
| Shares Outstanding (Diluted) | 286 | 380 | 341 | 233 | 158 | 99 |
| Shares Change (YoY) | -25.81% | 11.51% | 46.01% | 48.03% | 59.70% | - |
| EPS (Basic) | -3.96 | -0.65 | -6.30 | 0.23 | -0.14 | -0.12 |
| EPS (Diluted) | -3.97 | -0.65 | -6.30 | 0.20 | -0.14 | -0.12 |
| Free Cash Flow | -27.05 | 48.95 | -396.47 | -56.74 | -25.33 | -38.24 |
| Free Cash Flow Per Share | -0.09 | 0.13 | -1.16 | -0.24 | -0.16 | -0.39 |
| Gross Margin | 29.32% | 24.57% | 1.31% | 43.87% | 15.57% | 17.69% |
| Operating Margin | 6.09% | 2.95% | -67.04% | 24.66% | -20.12% | -18.07% |
| Profit Margin | -203.22% | -49.06% | -335.20% | 8.69% | -37.61% | -20.03% |
| Free Cash Flow Margin | -4.85% | 9.74% | -61.92% | -10.42% | -42.00% | -64.25% |
| EBITDA | 152.31 | 110.84 | -204.03 | 167.61 | -2.74 | -4.64 |
| EBITDA Margin | 27.31% | 22.06% | -31.86% | 30.78% | -4.54% | -7.79% |
| D&A For EBITDA | 118.37 | 96 | 225.26 | 33.36 | 9.4 | 6.12 |
| EBIT | 33.94 | 14.84 | -429.29 | 134.25 | -12.14 | -10.76 |
| EBIT Margin | 6.09% | 2.95% | -67.04% | 24.66% | -20.12% | -18.07% |
| Effective Tax Rate | - | - | - | 24.99% | - | - |
| Revenue as Reported | 557.68 | 502.4 | 640.31 | 544.48 | 60.32 | 59.52 |
Source: S&P Capital IQ. Standard template. Financial Sources.